Results from a phase I/II trial of tinostamustine monotherapy in advanced solid tumours (NCT03345485): Safety and efficacy in a subset of patients (pts) with soft tissue sarcoma (STS)

被引：0
|
作者：
Chugh, R. [1 ]
Kummar, S. [2 ]
Schneider, R. E. [3 ]
Janik, T. [4 ]
Manamley, N. [5 ]
Hilgier, K. [4 ]
Strauss, J. [3 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[2] OHSU Knight Canc Inst, Div Hematol & Med Oncol, Ctr Hlth & Healing, Bldg 1 South Waterfront, Portland, OR USA
[3] Mary Crowley Canc Res Ctr, Med Oncol Dept, Dallas, TX USA
[4] Mundipharma Res Ltd, Clin Dev Oncol & Hematol, Cambridge, England
[5] Mundipharma Int, R&D, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1957P
引用
收藏
页码：S1048 / S1048
页数：1
相关论文
共 50 条
  • [31] A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
    P A Cassier
    A Lefranc
    E Y Amela
    C Chevreau
    B N Bui
    A Lecesne
    I Ray-Coquard
    S Chabaud
    N Penel
    Y Berge
    J Dômont
    A Italiano
    F Duffaud
    A-C Cadore
    V Polivka
    J-Y Blay
    British Journal of Cancer, 2013, 109 : 909 - 914
  • [32] PROPEL: A phase I/II trial of bempegaldesleukin (NKTR-214) in combination with pembrolizumab (pembro) in patients (pts) with advanced solid tumours
    Reck, M.
    Cappuzzo, F.
    Rodriguez-Abreu, D.
    Cho, D. C.
    Schwarz, J. K.
    Riese, M. J.
    Gupta, A.
    Chan, T.
    Saab, R.
    Singel, S.
    Lin, W.
    Tagliaferri, M.
    Spigel, D. R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Efficacy and safety of anlotinib in advanced soft tissue sarcoma: results from one of multi-centers in a phase IIB trial (ALTER0203).
    Tang, Lina
    Wang, Yonggang
    Zhang, Jianjun
    Yu, Wenxi
    Huang, Yujing
    Yao, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Exatecan (DX-8951f), a new topoisomerase I-inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS):: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pink, D
    Reichardt, P
    Nielsen, S
    Bauer, S
    Hartmann, JT
    Schöffski, P
    van Oosterom, AT
    Daugaard, S
    Stoichkov, K
    Hermans, C
    Judson, IR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 830S - 830S
  • [35] NUC-7738 in patients with advanced solid tumours: Phase I results from the NuTide:701 phase I/II study
    Symeonides, S. N.
    Skolariki, A.
    Haris, N. R. M.
    Boh, Z.
    Myers, M.
    Oelmann, E. M.
    Bloss, J. D.
    Plummer, R.
    Blagden, S. P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S745 - S746
  • [36] A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
    Attia, Steven
    Bolejack, Vanessa
    Ganjoo, Kristen N.
    George, Suzanne
    Agulnik, Mark
    Rushing, Daniel
    Loggers, Elizabeth T.
    Livingston, Michael B.
    Wright, Jennifer
    Chawla, Sant P.
    Okuno, Scott H.
    Reinke, Denise K.
    Riedel, Richard F.
    Davis, Lara E.
    Ryan, Christopher W.
    Maki, Robert G.
    CANCER MEDICINE, 2023, 12 (02): : 1532 - 1539
  • [37] Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
    Cote, Gregory M.
    Haddox, Candace L.
    Choy, Edwin
    Merriam, Priscilla A.
    Mazzola, Emanuele
    Venkataraman, Vinayak
    Alcindor, Thierry
    Wagner, Andrew J.
    Demetri, George D.
    George, Suzanne
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2702 - 2708
  • [38] IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of the phase II-soft-tissue sarcoma cohort
    Martin Broto, J.
    Hindi, N.
    Grignani, G. E.
    Martinez Trufero, J.
    Redondo, A.
    Valverde, C.
    Lopez Pousa, A.
    Stacchiotti, S.
    Palmerini, E.
    de Alava, E.
    Moura, D. S.
    Perez Vega, H.
    Collini, P.
    Otero, I.
    Ledesma, P.
    Marchesi, E.
    D'Ambrosio, L.
    Lopez Martin, J. A.
    ANNALS OF ONCOLOGY, 2019, 30 : 684 - 684
  • [39] Efficacy and safety of apatinib in advanced soft tissue sarcoma: A multi-center, open-label phase II clinical trial.
    Yu, Wenxi
    Fan, Zhengfu
    Chen, Jing
    Zhang, Hong-Mei
    Zhang, Xing
    Qu, Guofan
    Chen, Yong
    Huang, Gang
    Yao, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Safety and efficacy of eribulin plus anlotinib in patients with advanced soft tissue sarcoma (ERAS): A multi-center phase II study
    Liu, Jie
    Deng, Yaotiao
    Wang, Ying
    Zhang, Jie
    Li, Mei
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345